Pamukcu A, Bush A, Buchdahl R
Department of Paediatric Respiratory Medicine, Royal Brompton National Heart and Lung Hospital, London, England.
Pediatr Pulmonol. 1995 Jan;19(1):10-5. doi: 10.1002/ppul.1950190103.
The aim of this study was to evaluate how lung function and growth changed over time in children with cystic fibrosis (CF) colonized with pseudomonas aeruginosa (Pa) compared with those free of the organism. A total of 192 children attended our cystic fibrosis clinic between 1982 and 1992. Sixty-two of these had three or more annual assessments for lung function, and 117 had three or more annual assessments for height and weight. When lung function was expressed as a standard deviation score (SDS), forced expiratory volume in 1 second (FEV1) and forced expiratory flow at 25% of vital capacity (FEF25) decreased significantly more with respect to height in colonized compared with noncolonized children: FEV1, -0.052 verses -0.015 SDS/cm (P < 0.05); FEF25, -0.060 verses -0.007 SDS/cm (P < 0.05); forced vital capacity (FVC), -0.034 versus -0.012 (NS). In actual values those patients colonized with Pa increased their FEV1 by 16.4 versus 31.6 mL/cm (P < 0.01); FVC by 28.8 versus 41.4 mL/cm, P < 0.01; and FEF25 by -0.001 versus 0.015 L/s/cm, P < 0.01. In terms of height, colonized children grew at 5.63 versus 6.96 cm/yr, P < 0.001, and height SDS decreased in colonized compared with noncolonized children at -0.031 verses 0.08 SDS/yr, P < 0.05. Clinically, most children with CF, with or without Pa, grew within +/- 1 SD of the norm for weight and height. However, in terms of lung function despite optimum pulmonary management colonized children deteriorated significantly faster.
本研究的目的是评估与未感染铜绿假单胞菌(Pa)的囊性纤维化(CF)儿童相比,感染该菌的CF儿童的肺功能和生长随时间如何变化。1982年至1992年间,共有192名儿童到我们的囊性纤维化诊所就诊。其中62名儿童接受了三次或更多次肺功能年度评估,117名儿童接受了三次或更多次身高和体重年度评估。当肺功能以标准差评分(SDS)表示时,与未感染儿童相比,感染儿童的一秒用力呼气容积(FEV1)和肺活量25%时的用力呼气流量(FEF25)相对于身高的下降幅度明显更大:FEV1,-0.052对比-0.015 SDS/cm(P<0.05);FEF25,-0.060对比-0.007 SDS/cm(P<0.05);用力肺活量(FVC),-0.034对比-0.012(无显著性差异)。以实际值计,感染Pa的患者FEV1增加了16.4对比31.6 mL/cm(P<0.01);FVC增加了28.8对比41.4 mL/cm,P<0.01;FEF25增加了-0.001对比0.015 L/s/cm,P<0.01。在身高方面,感染儿童的生长速度为5.63对比6.96 cm/年,P<0.001,与未感染儿童相比,感染儿童的身高SDS下降幅度为-0.031对比0.08 SDS/年,P<0.05。临床上,大多数CF儿童,无论是否感染Pa,其体重和身高增长均在正常范围的±1个标准差内。然而,在肺功能方面,尽管进行了最佳的肺部管理,感染儿童的病情恶化速度明显更快。